29.05.2013 • News • Brenntag • France • chemical industry

Brenntag Does Not Agree with Decision of French Competition Authority

Brenntag SA, a French subsidiary of Brenntag AG which represented about 4% of the Group's sales in 2012, has been informed today by the French Competition Authority (FCA) of the fine of €48 million imposed on Brenntag SA jointly with a further party regarding infringements to competition law, from 1998 to 2005 in France.

Brenntag SA does not agree with the legal qualification of the facts and the calculation of the fine of the FCA and will consider an appeal.

Brenntag France applied for leniency in 2006 and has actively contributed to the investigation and provided all information and proofs working closely together with the FCA regarding the clarification of the facts.

Brenntag Group is committed to free competition and does not tolerate any infringements of antitrust law. Brenntag regularly conducts substantial training programs and has comprehensive policies in place in order to strengthen this commitment.

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Top-Feature